# Anagram Therapeutics funding rounds and investors

As of 14 Oct 2026, Anagram Therapeutics has raised $250M across 1 verified round on record; latest: $250 million funding round, announced 7 May 2026.

Anagram Therapeutics develops breakthrough orally delivered enzyme therapeutics for rare and life-threatening diseases, primarily targeting malabsorption syndromes and nutrient metabolism disorders.

Website: https://anagramtx.com  
Headquarters: Natick, MA  
Page: https://fireround.dev/companies/anagramtx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-05-07 | Funding round | $250 million | not stated | Blackstone Life Sciences | [blackstone.com](https://www.blackstone.com/news/press/blackstone-life-sciences-invests-250-million-in-anagram-therapeutics-to-advance-novel-and-patient-friendly-oral-enzyme-replacement-therapy-for-pancreatic-insufficiency) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.